Skip to content
Loading…
US drugmakers Merck and Moderna said Wednesday a personalised cancer treatment had shown success in reducing the recurrence of melanoma tumors in a late-stage trial hailed by experts as a "breakthrough." Researchers have for years been trying to apply mRNA treatments against…
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on France 24.